Navigation Links
Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform
Date:8/19/2010

Broad Institute Acquires License to all ChemAxon products and Deploys... -- BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, August 19, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Software, Biotechnology, Chemical, Contracts, Joint Ventures, Licensing Click to view news release full screen  

Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform

 

BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, August 19, 2010 /PRNewswire/ --

- Compound Registration, Structure Search and Computed Properties Rolled Out

ChemAxon, a leading provider of chemistry software for life sciences, announced today that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon's platform, discovery toolkits and desktop applications for institute-wide use. Broad will support their legacy small molecule registration system and other functionality across their Chemical Biology Platform with ChemAxon's technology.

In addition to ChemAxon's discovery and desktop tools, the Broad Institute has already updated their core technology for archiving small molecules by deploying the JChem platform toolkit within their existing system.

"This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research," said Michael Foley, Director of the Broad's Chemical Biology Platform. "The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work."

The evaluation and deployment is to be presented during ChemAxon's User Group Meeting being held in Boston's Omni Parker House, September 14-15, the complete program is here: http://www.chemaxon.com/events/2010-us-ugm/

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.


'/>"/>
SOURCE ChemAxon Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
3. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
4. Nomad Bioscience Announces Broad License Agreement
5. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
6. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll
9. Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results
10. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
11. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ellen Matloff, president ... Technology Council (CTC) as a 2017 Women of Innovation® finalist. Matloff will be ... Awards Dinner. , The dinner recognizes women accomplished in science, technology, engineering and ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental ... samples to full-size tissues, bones, even whole organs to implant in people to ... blood deep into the developing tissue. , Current bioengineering techniques, including 3-D ...
Breaking Biology Technology:
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
Breaking Biology News(10 mins):